b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31272568</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>09</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1942-5546</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>94</Volume>\n                    <Issue>7</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>07</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Mayo Clinic proceedings</Title>\n                <ISOAbbreviation>Mayo Clin. Proc.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1199-1209</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0025-6196(19)30122-3</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mayocp.2018.11.037</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">To characterize the obese heart failure with preserved ejection fraction (HFpEF) phenotype in a multicenter cohort.</AbstractText>\n                <AbstractText Label="PATIENTS AND METHODS">This was a secondary analysis of the randomized clinical trial RELAX (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction) performed between October 1, 2008, and February 1, 2012. Patients with HFpEF were classified by body mass index (BMI) as obese (BMI\xe2\x89\xa535 kg/m<sup>2</sup>) and nonobese (BMI&lt;30 kg/m<sup>2</sup>) for comparison.</AbstractText>\n                <AbstractText Label="RESULTS">Obese patients with HFpEF (n=81) were younger (median age, 64 [interquartile range (IQR), 67-79] years vs 73 [IQR, 56-70] years; P&lt;.001) but had greater peripheral edema (31% [25] vs 9% [6]; P&lt;.001), more orthopnea (76% [56] vs 53% [35]; P=.005), worse New York Heart Association class (P=.006), and more impaired quality of life (P&lt;.001) as compared with nonobese patients with HFpEF (n=70). Despite more severe signs and symptoms, obese patients with HFpEF had lower N-terminal pro B-type natriuretic peptide level (median, 481 [IQR, 176-1183] pg/mL vs 825 [IQR, 380-1679] pg/mL [to convert to pmol/L, multiply by 0.118]; P=.007) and lower left atrial volume index (median, 38 [IQR, 31-47] mL/m<sup>2</sup> vs 54 [IQR, 41-63] mL/m<sup>2</sup>; P&lt;.001). Serum C-reactive protein (median, 5.0 [IQR, 2.4-9.9] mg/dL vs 2.7 [IQR, 1.6-5.4] mg/dL [to convert to mg/L, multiply by 10<sup>-3</sup>]; P&lt;.001) and uric acid (median, 7.8 [IQR, 6.1-8.7] mg/dL vs 6.8 [IQR, 5.5-8.3] mg/dL; P=.03) levels were higher in obese HFpEF, indicating greater systemic inflammation, than in nonobese HFpEF. Peak oxygen consumption was impaired in obese HFpEF (median, 11.1 [IQR, 9.6-14.4] mL/kg per minute vs 13.1 [IQR, 11.3-14.7] mL/kg per minute; P=.008), as was submaximal exercise capacity (6-minute walk distance, 272 [IQR, 200-332] m vs 355 [IQR, 290-415] m; P&lt;.0001).</AbstractText>\n                <AbstractText Label="CONCLUSION">Obese HFpEF is associated with decreased quality of life, worse symptoms of heart failure, greater systemic inflammation, worse exercise capacity, and higher metabolic cost of exertion as compared with nonobese HFpEF. Further study is required to understand the pathophysiology and potential distinct treatments for patients with the obese phenotype of HFpEF.</AbstractText>\n                <AbstractText Label="TRIAL REGISTRATION">clinicaltrials.gov Identifier: NCT00763867.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Reddy</LastName>\n                    <ForeName>Yogesh N V</ForeName>\n                    <Initials>YNV</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lewis</LastName>\n                    <ForeName>Gregory D</ForeName>\n                    <Initials>GD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Massachusetts General Hospital, Boston.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shah</LastName>\n                    <ForeName>Sanjiv J</ForeName>\n                    <Initials>SJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Northwestern University, Chicago, IL.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Obokata</LastName>\n                    <ForeName>Masaru</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Abou-Ezzedine</LastName>\n                    <ForeName>Omar F</ForeName>\n                    <Initials>OF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fudim</LastName>\n                    <ForeName>Marat</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Duke University, Durham, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sun</LastName>\n                    <ForeName>Jie-Lena</ForeName>\n                    <Initials>JL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Duke University, Durham, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chakraborty</LastName>\n                    <ForeName>Hrishikesh</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Duke University, Durham, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>McNulty</LastName>\n                    <ForeName>Steven</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Duke University, Durham, NC.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>LeWinter</LastName>\n                    <ForeName>Martin M</ForeName>\n                    <Initials>MM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, University of Vermont, Burlington.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mann</LastName>\n                    <ForeName>Douglas L</ForeName>\n                    <Initials>DL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Washington University, St. Louis, MO.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stevenson</LastName>\n                    <ForeName>Lynne W</ForeName>\n                    <Initials>LW</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Vanderbilt University, Nashville, TN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Redfield</LastName>\n                    <ForeName>Margaret M</ForeName>\n                    <Initials>MM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Borlaug</LastName>\n                    <ForeName>Barry A</ForeName>\n                    <Initials>BA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN. Electronic address: borlaug.barry@mayo.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <DataBankList CompleteYN="Y">\n                <DataBank>\n                    <DataBankName>ClinicalTrials.gov</DataBankName>\n                    <AccessionNumberList>\n                        <AccessionNumber>NCT00763867</AccessionNumber>\n                    </AccessionNumberList>\n                </DataBank>\n            </DataBankList>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>T32 HL007111</GrantID>\n                    <Acronym>HL</Acronym>\n                    <Agency>NHLBI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Mayo Clin Proc</MedlineTA>\n            <NlmUniqueID>0405543</NlmUniqueID>\n            <ISSNLinking>0025-6196</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D058986">Phosphodiesterase 5 Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C109794">pro-brain natriuretic peptide (1-76)</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>114471-18-0</RegistryNumber>\n                <NameOfSubstance UI="D020097">Natriuretic Peptide, Brain</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>BW9B0ZE037</RegistryNumber>\n                <NameOfSubstance UI="D000068677">Sildenafil Citrate</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>AIM</CitationSubset>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020097" MajorTopicYN="N">Natriuretic Peptide, Brain</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>\n                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D058986" MajorTopicYN="N">Phosphodiesterase 5 Inhibitors</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000068677" MajorTopicYN="N">Sildenafil Citrate</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName>\n                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>6</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31272568</ArticleId>\n            <ArticleId IdType="pii">S0025-6196(19)30122-3</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.mayocp.2018.11.037</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'